BrainStorm Cell Therapeutics
analysis methods samples over weeks collected prior to and after each treatment validated assays at thermo fisher ray and statistical analysis plan submitted to before trial due to skewness in the distribution data are log transformed for statistical analysis three main analyses principal component analysis used data from the treatment period and specified biological pathways to identify groups of relevant individual trajectories plotted using an model prediction of response mixed stepwise regression model selected significant predicting response to | BrainStorm Cell Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
6 of 15
Related slides by other companies
Confluent
Investor Day
October 2022
| Confluent
Confluent
Investor Day
October 2022
| Confluent
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights